Your browser doesn't support javascript.
loading
Accelerating Global Measles and Rubella Eradication-Saving Millions of Lives, Preventing Disability, and Averting the Next Pandemic.
Durrheim, David N; Andrus, Jon K; Tabassum, Shahina; Githanga, David; Kojouharova, Mira; Talab, Nadia.
Afiliação
  • Durrheim DN; School of Medicine and Public Health, University of Newcastle, Newcastle 2308, Australia.
  • Andrus JK; Department of Global Health, Milken Institute of Public Health, George Washington University, Washington, DC 20052, USA.
  • Tabassum S; Department of Virology, Bangabandhu Sheikh Mujib Medical University, Dhaka 1000, Bangladesh.
  • Githanga D; Kenya Paediatrics Association, Nairobi P.O. Box 45820-00100, Kenya.
  • Kojouharova M; National Centre of Infectious and Parasitic Diseases, 1504 Sofia, Bulgaria.
  • Talab N; Regional Office of Eastern Mediterranean, Cairo 11371, Egypt.
Vaccines (Basel) ; 12(6)2024 Jun 20.
Article em En | MEDLINE | ID: mdl-38932428
ABSTRACT
No vaccine has been more effective in reducing disease burden, especially in preventing child deaths, than measles-containing vaccine. The return on investment makes measles-containing vaccine one of the most cost-effective public health measures available. Exhaustive reviews of biological, technical, economic and programmatic evidence have concluded that measles can and should be eradicated, and by including rubella antigen in measles-containing vaccine, congenital rubella syndrome will also be eradicated. All World Health Organisation Regions have pledged to achieve measles elimination. Unfortunately, not all countries and global partners have demonstrated an appropriate commitment to these laudable public health goals, and the negative impact of the COVID-19 pandemic on coverage rates has been profound. Unsurprisingly, large disruptive outbreaks are already occurring in many countries with a global epidemic curve ominously similar to that of 2018/2019 emerging. The Immunization Agenda 2030 will fail dismally unless measles and rubella eradication efforts are accelerated. Over half of all member states have been verified to have eliminated rubella and endemic rubella transmission has not been re-established in any country to date. In 2023, 84 countries and areas were verified to have sustained elimination of measles. However, without a global target, this success will be difficult to sustain. Now is the time for a global eradication goal and commitment by the World Health Assembly. Having a galvanising goal, with a shared call for action, will demand adequate resourcing from every country government and global partners. Greater coordination across countries and regions will be necessary. Measles, rubella and congenital rubella syndrome eradication should not remain just a technically feasible possibility but rather be completed to ensure that future generations of children do not live under the shadow of preventable childhood death and lifelong disability.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Vaccines (Basel) Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Austrália

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Vaccines (Basel) Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Austrália